{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:21:57Z","timestamp":1777562517285,"version":"3.51.4"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eat Weight Disord"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s40519-019-00774-w","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T18:05:36Z","timestamp":1568311536000},"page":"1129-1140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Obesity and hormonal contraception: an overview and a clinician\u2019s practical guide"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3315-2951","authenticated-orcid":false,"given":"Sarah","family":"Cipriani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Todisco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Scavello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenza","family":"Di Stasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1472-6051","authenticated-orcid":false,"given":"Elisa","family":"Maseroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0907-0630","authenticated-orcid":false,"given":"Linda","family":"Vignozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,12]]},"reference":[{"issue":"4","key":"774_CR1","doi-asserted-by":"publisher","first-page":"e380","DOI":"10.1016\/S2214-109X(18)30029-9","volume":"6","author":"J Bearak","year":"2018","unstructured":"Bearak J et al (2018) Global, regional, and subregional trends in unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian hierarchical model. Lancet Glob Health 6(4):e380\u2013e389","journal-title":"Lancet Glob Health"},{"issue":"6","key":"774_CR2","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.2337\/dc08-2105","volume":"32","author":"A Vahratian","year":"2009","unstructured":"Vahratian A et al (2009) Family-planning practices among women with diabetes and overweight and obese women in the 2002 National Survey For Family Growth. Diabetes Care 32(6):1026\u20131031","journal-title":"Diabetes Care"},{"issue":"6","key":"774_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1467-789X.2008.00511.x","volume":"9","author":"N Heslehurst","year":"2008","unstructured":"Heslehurst N, Simpson H et al (2008) The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis. Obes Rev 9(6):635\u2013683","journal-title":"Obes Rev"},{"issue":"356","key":"774_CR4","doi-asserted-by":"publisher","first-page":"j1","DOI":"10.1136\/bmj.j1","volume":"8","author":"PM Catalano","year":"2017","unstructured":"Catalano PM, Shankar K (2017) Obesity\u00a0and\u00a0pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ 8(356):j1","journal-title":"BMJ"},{"issue":"10","key":"774_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1097\/OGX.0000000000000115","volume":"69","author":"CA Marsh","year":"2014","unstructured":"Marsh CA, Hecker E (2014) Maternal obesity and adverse reproductive outcomes. Obstet Gynecol Surv 69(10):622\u2013628","journal-title":"Obstet Gynecol Surv"},{"key":"774_CR6","unstructured":"EPAR (European Public Assessment Reports)\u2014product Information for naltrexone\/bupropione. \n                  https:\/\/www.ema.europa.eu\/en\/documents\/overview\/mysimba-epar-summary-public_en.pdf\n                  \n                . Accessed 9 Sept 2019"},{"key":"774_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-019-04084-z","author":"MA Damhof","year":"2019","unstructured":"Damhof MA et al (2019) Assessment of contraceptive counseling and contraceptive use in women after bariatric surgery. Obes Surg. \n                  https:\/\/doi.org\/10.1007\/s11695-019-04084-z","journal-title":"Obes Surg"},{"key":"774_CR8","first-page":"1","volume":"288","author":"CM Hales","year":"2017","unstructured":"Hales CM et al (2017) Prevalence of obesity among adults and youth: United States, 2015\u20132016. Natl Cent Health Stat Data Brief 288:1\u20138","journal-title":"Natl Cent Health Stat Data Brief"},{"issue":"2","key":"774_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ejvs.2006.10.006","volume":"33","author":"KA Darvall","year":"2007","unstructured":"Darvall KA et al (2007) Obesity and thrombosis. Eur J Vasc Endovasc Surg 33(2):223\u2013233","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"774_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.contraception.2009.04.011","volume":"80","author":"AB Edelman","year":"2009","unstructured":"Edelman AB, Carlson NE et al (2009) Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity. Contraception 80(2):119\u2013127","journal-title":"Contraception"},{"issue":"5","key":"774_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.contraception.2019.01.003","volume":"99","author":"M Natavio","year":"2019","unstructured":"Natavio M et al (2019) Pharmacokinetics\u00a0of the\u00a01.5\u00a0mg\u00a0levonorgestrel\u00a0emergency\u00a0contraceptive\u00a0in women with normal, obese and extremely obese body mass index. Contraception 99(5):306\u2013311","journal-title":"Contraception"},{"issue":"1","key":"774_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.beem.2012.11.004","volume":"27","author":"S Christin-Maitre","year":"2013","unstructured":"Christin-Maitre S (2013) History of oral contraceptive drugs and their use worldwide. Best Pract Res Clin Endocrinol Metab 27(1):3\u201312","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"774_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/humupd\/dmt038","volume":"20","author":"Y Zimmerman","year":"2014","unstructured":"Zimmerman Y et al (2014) The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Hum Reprod Update 20(1):76\u2013105","journal-title":"Hum Reprod Update"},{"issue":"5","key":"774_CR14","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1172\/JCI116437","volume":"91","author":"BW Walsh","year":"1993","unstructured":"Walsh BW, Sacks FM (1993) Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism. J Clin Investig 91(5):2126\u20132132","journal-title":"J Clin Investig"},{"key":"774_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.maturitas.2003.11.009","volume":"47","author":"HJ Coelingh Bennink","year":"2004","unstructured":"Coelingh Bennink HJ (2004) Are all estrogens the same? Maturitas 47:269\u2013275","journal-title":"Maturitas"},{"issue":"1","key":"774_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1055\/s-0038-1646528","volume":"61","author":"UB Lindberg","year":"1989","unstructured":"Lindberg UB et al (1989) A comparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters. J Thromb Haemost 61(1):65\u201369","journal-title":"J Thromb Haemost"},{"issue":"1","key":"774_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.beem.2012.09.004","volume":"27","author":"R Sitruk-Ware","year":"2013","unstructured":"Sitruk-Ware R, Nath A (2013) Characteristics and metabolic effects of estrogen and\u00a0progestins contained in oral contraceptive pills. Best Pract Res Clin Endocrinol Metab 27(1):13\u201324","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"7","key":"774_CR18","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/0002-9378(85)90664-7","volume":"151","author":"U Goebelsmann","year":"1985","unstructured":"Goebelsmann U, Mashchak CA, Mishell DR Jr (1985) Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol. Am J Obstet Gynecol 151(7):868\u2013877","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"774_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/jth.12054","volume":"11","author":"BH Stegeman","year":"2013","unstructured":"Stegeman BH et al (2013) Effect of ethinylestradiol dose and progestagen in combined oral contraceptives on plasma sex hormone-binding globulin levels in premenopausal women. J Thromb Haemost 11(1):203\u2013205","journal-title":"J Thromb Haemost"},{"issue":"7","key":"774_CR20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.tem.2015.05.001","volume":"26","author":"R Sim\u00f3","year":"2015","unstructured":"Sim\u00f3 R, S\u00e1ez-L\u00f3pez C et al (2015) Novel insights in SHBG regulation and clinical implications. Trends Endocrinol Metab 26(7):376\u2013383","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"774_CR21","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1210\/jc.2007-0026","volume":"92","author":"R Sitruk-Ware","year":"2007","unstructured":"Sitruk-Ware R, Plu-Bureau G et al (2007) Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study. J Clin Endocrinol Metab 92(6):2074\u20132079","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"774_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.contraception.2007.01.027","volume":"75","author":"RL Sitruk-Ware","year":"2007","unstructured":"Sitruk-Ware RL, Menard J et al (2007) Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen. Contraception 75(6):430\u2013437","journal-title":"Contraception"},{"key":"774_CR23","first-page":"CD010813","volume":"3","author":"M De Bastos","year":"2014","unstructured":"De Bastos M, Stegeman BH et al (2014) Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev 3:CD010813","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"774_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF03190010","volume":"24","author":"CJ Timmer","year":"1999","unstructured":"Timmer CJ, Geurts TB (1999) Bioequivalence assessment of three different estradiol formulations in postmenopausal women in an open, randomized, single-dose, 3-way cross-over study. Eur J Drug Metab Pharmacokinet 24(1):47\u201353","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"5","key":"774_CR25","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/jth.12172","volume":"11","author":"M Raps","year":"2013","unstructured":"Raps M, Rosendaal F et al (2013) Resistance\u00a0to APC and\u00a0SHBG\u00a0levels\u00a0during use of a\u00a0four-phasic\u00a0oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial. J Thromb Haemost 11(5):855\u2013861","journal-title":"J Thromb Haemost"},{"issue":"1\u20132","key":"774_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.maturitas.2008.11.013","volume":"61","author":"AE Schindler","year":"2008","unstructured":"Schindler AE et al (2008) Classification and pharmacology of progestins. Maturitas 61(1\u20132):171\u2013180","journal-title":"Maturitas"},{"key":"774_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.metabol.2017.05.001","volume":"73","author":"M Amiri","year":"2017","unstructured":"Amiri M, Ramezani Tehrani F et al (2017) Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: a meta-analysis comparing products containing cyproterone acetate with third generation progestins. Metabolism 73:22\u201335","journal-title":"Metabolism"},{"issue":"5","key":"774_CR28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.contraception.2010.04.004","volume":"82","author":"R Sitruk-Ware","year":"2010","unstructured":"Sitruk-Ware R, Nath A (2010) The use of newer progestins for contraception. Contraception 82(5):410\u2013417","journal-title":"Contraception"},{"issue":"1","key":"774_CR29","first-page":"31","volume":"33","author":"SL McElroy","year":"2019","unstructured":"McElroy SL, Guerdjikova AI, Mori N, Romo-Nava F (2019) Progress\u00a0in\u00a0developing\u00a0pharmacologic\u00a0agents\u00a0to\u00a0treat\u00a0bulimia nervosa. Cent Nerv Syst Drugs 33(1):31\u201346","journal-title":"Cent Nerv Syst Drugs"},{"key":"774_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1055\/s-0037-1612973","volume":"87","author":"JM Kemmeren","year":"2002","unstructured":"Kemmeren JM, Algra A et al (2002) Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation. J Thromb Haemost 87:199\u2013205","journal-title":"J Thromb Haemost"},{"key":"774_CR31","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/blood-2003-04-1285","volume":"103","author":"JM Kemmeren","year":"2004","unstructured":"Kemmeren JM et al (2004) Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor V Leiden mutation: a randomized trial. Blood 103:927\u2013933","journal-title":"Blood"},{"issue":"6","key":"774_CR32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3109\/13625187.2011.614029","volume":"16","author":"D Mansour","year":"2011","unstructured":"Mansour D et al (2011) Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol in a 24\/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21\/7 regimen. Eur J Contracept Reprod Health Care 16(6):430\u2013443","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"774_CR33","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.contraception.2012.12.006","volume":"87","author":"H Fels","year":"2013","unstructured":"Fels H, Steward R, Melamed A et al (2013) Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24\/4 vs 21\/7 combined oral contraceptives. J Contracept 87(6):732\u2013737","journal-title":"J Contracept"},{"issue":"11","key":"774_CR34","first-page":"003553","volume":"9","author":"HA Van Vliet","year":"2011","unstructured":"Van Vliet HA et al (2011) Triphasic versus monophasic oral contraceptives for contraception. Cochrane Database Syst Rev 9(11):003553","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"774_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","volume":"72","author":"MW Van den Heuvel","year":"2005","unstructured":"Van den Heuvel MW, van Bragt AJ et al (2005) Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. Contraception 72(3):168\u2013174","journal-title":"Contraception"},{"issue":"2","key":"774_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.0306-5251.2001.01532.x","volume":"53","author":"LS Abrams","year":"2002","unstructured":"Abrams LS, Skee DM et al (2002) Pharmacokinetics of a contraceptive patch (Evra\u2122\/Ortho Evra\u2122) containing norelgestromin and ethinyloestradiol at four application sites. Br J Clin Pharmacol 53(2):141\u2013146","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"774_CR37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3109\/13625187.2012.713535","volume":"17","author":"FJME Roumen","year":"2012","unstructured":"Roumen FJME, Mishell DR Jr (2012) The contraceptive vaginal ring, NuvaRing\u00ae, a decade after its introduction. Eur J Contracept Reprod Health Care 17(6):415\u2013427","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"774_CR38","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.contraception.2006.07.004","volume":"74","author":"HJ Ahrendt","year":"2006","unstructured":"Ahrendt HJ et al (2006) Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 mcg of ethinyl estradiol and 3\u00a0mg of drospirenone. Contraception 74:451\u2013457","journal-title":"Contraception"},{"key":"774_CR39","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.contraception.2004.09.001","volume":"71","author":"K Oddsson","year":"2005","unstructured":"Oddsson K et al (2005) Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial. Contraception 71:176\u2013182","journal-title":"Contraception"},{"issue":"9","key":"774_CR40","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/0026-0495(80)90117-1","volume":"29","author":"MT Buckman","year":"1980","unstructured":"Buckman MT, Johnson J et al (1980) Differential lipemic and proteinemic response to oral ethinyl estradiol and parenteral estradiol cypionate. Metab Clin Exp 29(9):803\u2013805","journal-title":"Metab Clin Exp"},{"issue":"6","key":"774_CR41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.contraception.2008.07.004","volume":"78","author":"JT Jensen","year":"2008","unstructured":"Jensen JT, Burke AE et al (2008) Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis. Contraception 78(6):451\u2013458","journal-title":"Contraception"},{"issue":"4","key":"774_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.contraception.2008.10.012","volume":"79","author":"G Bachmann","year":"2009","unstructured":"Bachmann G, Korner P (2009) Bleeding patterns associated with non-oral hormonal contraceptives: a review of the literature. Contraception 79(4):247\u2013258","journal-title":"Contraception"},{"issue":"4 Suppl","key":"774_CR43","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.ajog.2011.04.033","volume":"205","author":"AE Burke","year":"2011","unstructured":"Burke AE (2011) The state of hormonal contraception today: benefits and risks of hormonal contraceptives: progestin-only contraceptives. Am J Obstet Gynecol 205(4 Suppl):S14\u2013S17","journal-title":"Am J Obstet Gynecol"},{"key":"774_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.contraception.2010.02.002","volume":"82","author":"N Kapp","year":"2010","unstructured":"Kapp N, Curtis K, Nanda K (2010) Progestogen-only contraceptive use among breastfeeding women: a systematic review. Contraception 82:17\u201337","journal-title":"Contraception"},{"issue":"2","key":"774_CR45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0010-7824(88)90041-8","volume":"38","author":"EM Belsey","year":"1988","unstructured":"Belsey EM, D\u2019Arcangues C, Carlson N (1988) Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. II. The influence of individual characteristics. Contraception 38(2):243\u2013257","journal-title":"Contraception"},{"issue":"5","key":"774_CR46","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ajog.2016.12.008","volume":"216","author":"RE Zigler","year":"2017","unstructured":"Zigler RE, McNicholas C (2017) Unscheduled vaginal bleeding with progestin-only contraceptive use. Am J Obstet Gynecol 216(5):443\u2013450","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"774_CR47","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jama.2018.8877","volume":"320","author":"JP Wu","year":"2018","unstructured":"Wu JP, Moniz MH, Ursu AN (2018) Long-acting reversible contraception\u2014highly efficacious, safe, and underutilized. J Am Med Assoc 320(4):397\u2013398","journal-title":"J Am Med Assoc"},{"issue":"6","key":"774_CR48","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0015-0282(16)49397-0","volume":"45","author":"CG Nilsson","year":"1986","unstructured":"Nilsson CG, Lahteenmaki PLA, Luukkainen T, Robertson DN (1986) Sustained intrauterine release of levonorgestrel over five years. Fertil Steril 45(6):805\u2013807","journal-title":"Fertil Steril"},{"issue":"2","key":"774_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.soard.2006.03.014","volume":"2","author":"K Allison","year":"2006","unstructured":"Allison K et al (2006) Night eating syndrome and binge eating disorder among persons seeking bariatric surgery: prevalence and related features. Surg Obes Relat Dis 2(2):153\u2013158. \n                  https:\/\/doi.org\/10.1016\/j.soard.2006.03.014","journal-title":"Surg Obes Relat Dis"},{"key":"774_CR50","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s40519-017-0391-z","volume":"22","author":"BA Mac Neil","year":"2017","unstructured":"Mac Neil BA et al (2017) A case of symptom relapse post placement of intrauterine device (IUD) in a patient with bulimia nervosa: consequence or coincidence. Eat Weight Disord Stud Anorex Bulim Obes 22:369","journal-title":"Eat Weight Disord Stud Anorex Bulim Obes"},{"key":"774_CR51","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1055\/s-0030-1248137","volume":"28","author":"G Roy","year":"2010","unstructured":"Roy G (2010) Injectable contraception. Semin Reprod Med 28:126\u2013132","journal-title":"Semin Reprod Med"},{"issue":"6","key":"774_CR52","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.bpobgyn.2014.05.003","volume":"28","author":"R Jacobstein","year":"2014","unstructured":"Jacobstein R, Polis CB (2014) Progestin-only contraception: injectables and implants. Best Pract Res Clin Obstet Gynecol 28(6):795\u2013806","journal-title":"Best Pract Res Clin Obstet Gynecol"},{"key":"774_CR53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.contraception.2009.02.008","volume":"80","author":"D Hubacher","year":"2009","unstructured":"Hubacher D, Lopez L, Steiner MJ, Dorflinger L (2009) Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons. Contraception 80:113\u2013118","journal-title":"Contraception"},{"issue":"5","key":"774_CR54","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.contraception.2010.05.016","volume":"82","author":"A Nath","year":"2010","unstructured":"Nath A, Sitruk-Ware R (2010) Progesterone vaginal ring for contraceptive use during lactation. Contraception 82(5):428\u2013434","journal-title":"Contraception"},{"issue":"1","key":"774_CR55","first-page":"CD003987","volume":"29","author":"MF Gallo","year":"2014","unstructured":"Gallo MF et al (2014) Combination contraceptives: effects on weight. Cochrane Database Syst Rev 29(1):CD003987","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"774_CR56","first-page":"CD008815","volume":"28","author":"LM Lopez","year":"2013","unstructured":"Lopez LM, Edelman A et al (2013) Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev 28(8):CD008815","journal-title":"Cochrane Database Syst Rev"},{"key":"774_CR57","first-page":"193","volume-title":"Oral contraceptives","author":"AL Nelson","year":"2007","unstructured":"Nelson AL (2007) Combined hormonal contraceptive methods. In: Hatcher RA et al (eds) Oral contraceptives, 19th edn. Contraceptive Technologies Inc, New York, pp 193\u2013270","edition":"19"},{"key":"774_CR58","doi-asserted-by":"publisher","first-page":"R807","DOI":"10.1152\/ajpregu.2001.280.3.R807","volume":"280","author":"AK Kang","year":"2001","unstructured":"Kang AK, Duncan JA et al (2001) Effect of oral contraceptives on the renin angiotensin system and renal function. Am J Physiol Regul Integr Comp Physiol 280:R807\u2013R813","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"774_CR59","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/00004872-199204000-00007","volume":"10","author":"MS Gordon","year":"1992","unstructured":"Gordon MS, Chin WW, Shupnik MA (1992) Regulation of angiotensinogen gene expression by estrogen. J Hypertens 10:361\u2013366","journal-title":"J Hypertens"},{"key":"774_CR60","volume-title":"Human anatomy and physiology","author":"EN Marieb","year":"2013","unstructured":"Marieb EN, Hoehn K (2013) Human anatomy and physiology. Pearson, London"},{"issue":"4","key":"774_CR61","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.contraception.2016.12.006","volume":"95","author":"PN Silva Dos Santos","year":"2017","unstructured":"Silva Dos Santos PN et al (2017) Changes in body composition in women using long-acting reversible\u00a0contraception. Contraception 95(4):382\u2013389","journal-title":"Contraception"},{"issue":"6","key":"774_CR62","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/0010-7824(80)90087-6","volume":"22","author":"K Amatayakul","year":"1980","unstructured":"Amatayakul K, Sivasomboon B, Thanangkul O (1980) A study of the\u00a0mechanism\u00a0of\u00a0weight gain\u00a0in medroxyprogesterone acetate users. Contraception 22(6):605\u2013622","journal-title":"Contraception"},{"issue":"1","key":"774_CR63","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/jwh.2012.4241","volume":"23","author":"ER Mayeda","year":"2014","unstructured":"Mayeda ER, Torgal AH, Westhoff CL (2014) Weight and body composition changes during oral contraceptive use in obese and normal weight women. J Women\u2019s Health (Larchmt) 23(1):38\u201343","journal-title":"J Women\u2019s Health (Larchmt)"},{"issue":"3","key":"774_CR64","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0015-0282(16)57419-6","volume":"63","author":"BE Reubinoff","year":"1995","unstructured":"Reubinoff BE et al (1995) Effects of low-dose estrogen oral contraceptives on weight, body composition, and fat distribution in young women. Fertil Steril 63(3):516","journal-title":"Fertil Steril"},{"key":"774_CR65","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.0001-6349.2004.00574.x","volume":"83","author":"E Samuelsson","year":"2004","unstructured":"Samuelsson E, Staffan HA (2004) Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users. Acta Obstet Gynecol Scand 83:674\u2013681","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"774_CR66","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijgo.2010.12.003","volume":"112","author":"R Reid","year":"2011","unstructured":"Reid R et al (2011) Oral contraceptives and the risk of venous thromboembolism: an update. Int J Gynecol Obstet 112(3):252\u2013256. \n                  https:\/\/doi.org\/10.1016\/j.ijgo.2010.12.003","journal-title":"Int J Gynecol Obstet"},{"issue":"22","key":"774_CR67","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1001\/archinte.160.22.3415","volume":"160","author":"MM Samama","year":"2000","unstructured":"Samama MM (2000) An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 160(22):3415\u20133420","journal-title":"Arch Intern Med"},{"issue":"24","key":"774_CR68","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1056\/NEJM200012143432403","volume":"343","author":"HR White","year":"2000","unstructured":"White HR, Gettner S, Newman J, Trauner KB, Romano SP (2000) Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med 343(24):1758\u20131764","journal-title":"N Engl J Med"},{"issue":"3","key":"774_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6503a1","volume":"65","author":"KM Curtis","year":"2016","unstructured":"Curtis KM et al (2016) U.S. medical eligibility criteria for contraceptive use. MMWR Recomm Rep 65(3):1\u2013103. \n                  https:\/\/doi.org\/10.15585\/mmwr.rr6503a1","journal-title":"MMWR Recomm Rep"},{"key":"774_CR70","volume-title":"Medical\u00a0eligibility\u00a0criteria\u00a0for\u00a0contraceptive\u00a0use","author":"WHO","year":"2015","unstructured":"WHO (2015) Medical\u00a0eligibility\u00a0criteria\u00a0for\u00a0contraceptive\u00a0use, 5th edn. World Health Organization, Geneva","edition":"5"},{"key":"774_CR71","unstructured":"UKMEC (2016) UK Medical Eligibility Criteria for Contraceptive Use (UKMEC 2016), Faculty of Sexual and Reproductive Healthcare. \n                  http:\/\/www.fsrh.org\/pdfs\/UKMEC2016.pdf\n                  \n                . Accessed 9 Sept 2019"},{"issue":"1","key":"774_CR72","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.fertnstert.2016.09.027","volume":"107","author":"Practice Committee of the American Society for Reproductive Medicine, Practice Committee of the American Society for Reproductive Medicine","year":"2017","unstructured":"Practice Committee of the American Society for Reproductive Medicine, Practice Committee of the American Society for Reproductive Medicine (2017) Combined hormonal contraception and the risk of venous thromboembolism: a guideline. Fertil Steril 107(1):43\u201351","journal-title":"Fertil Steril"},{"key":"774_CR73","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2011.1.150","author":"S Middeldorp","year":"2011","unstructured":"Middeldorp S (2011) Is thrombophilia testing useful? Hematology. Am Soc Hematol Educ Prog. \n                  https:\/\/doi.org\/10.1182\/asheducation-2011.1.150","journal-title":"Am Soc Hematol Educ Prog"},{"issue":"7","key":"774_CR74","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/jth.13349","volume":"14","author":"EFW Van Vlijmen","year":"2016","unstructured":"Van Vlijmen EFW, Wiewel-Verschueren S, Monster TBM, Meijer K (2016) Combined oral contraceptives, thrombophilia and the risk of thromboembolism: a systematic review and meta-analysis. J Thromb Haemost 14(7):1393\u20131403","journal-title":"J Thromb Haemost"},{"issue":"1","key":"774_CR75","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/01.AOG.0000149155.11912.52","volume":"105","author":"VL Holt","year":"2005","unstructured":"Holt VL, Scholes D, Wicklund KG, Cushing-Haugen KL, Daling JR (2005) Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol 105(1):46\u201352","journal-title":"Obstet Gynecol"},{"issue":"5","key":"774_CR76","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.contraception.2015.07.016","volume":"92","author":"M Yamazaki","year":"2015","unstructured":"Yamazaki M, Dwyer K et al (2015) Effect of obesity on the effectiveness of hormonal contraceptives: an individual participant data meta-analysis. Contraception 92(5):445\u2013452","journal-title":"Contraception"},{"issue":"2","key":"774_CR77","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.contraception.2012.10.008","volume":"87","author":"AB Edelman","year":"2013","unstructured":"Edelman AB et al (2013) Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users. Contraception 87(2):220\u2013226. \n                  https:\/\/doi.org\/10.1016\/j.contraception.2012.10.008","journal-title":"Contraception"},{"issue":"3","key":"774_CR78","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/AOG.0b013e31828317cc","volume":"121","author":"C McNicholas","year":"2013","unstructured":"McNicholas C et al (2013) Contraceptive failures in overweight and obese combined hormonal contraceptive users. Obstet Gynecol 121(3):585\u2013592. \n                  https:\/\/doi.org\/10.1097\/AOG.0b013e31828317cc","journal-title":"Obstet Gynecol"},{"issue":"4","key":"774_CR79","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.contraception.2018.12.009","volume":"99","author":"D Luo","year":"2019","unstructured":"Luo D, Westhoff CL et al (2019) Altered pharmacokinetics of combined oral contraceptives in obesity\u2014multistudy assessment. Contraception 99(4):256\u2013263","journal-title":"Contraception"},{"issue":"1","key":"774_CR80","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1210\/jc.2002-020982","volume":"88","author":"S Taponen","year":"2003","unstructured":"Taponen S et al (2003) Hormonal profile of women with self-reported symptoms of oligomenorrhea and\/or hirsutism: Northern Finland birth cohort 1966 study. J Clin Endocrinol Metab 88(1):141\u2013147. \n                  https:\/\/doi.org\/10.1210\/jc.2002-020982","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"774_CR81","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1210\/jc.2018-00241","volume":"103","author":"KA Martin","year":"2018","unstructured":"Martin KA, Anderson RR et al (2018) Evaluation and treatment of\u00a0hirsutism\u00a0in premenopausal women: an\u00a0Endocrine\u00a0Society\u00a0clinical practice\u00a0guideline. J Clin Endocrinol Metab 103(4):1233\u20131257","journal-title":"J Clin Endocrinol Metab"},{"key":"774_CR82","doi-asserted-by":"publisher","first-page":"e4944","DOI":"10.1136\/bmj.e494","volume":"345","author":"S Mantha","year":"2012","unstructured":"Mantha S, Karp R, Raghavan V et al (2012) Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. Br Med J 345:e4944\u2013e4944. \n                  https:\/\/doi.org\/10.1136\/bmj.e494","journal-title":"Br Med J"},{"key":"774_CR83","doi-asserted-by":"publisher","first-page":"d6423","DOI":"10.1136\/bmj.d6423","volume":"343","author":"O Lidegaard","year":"2011","unstructured":"Lidegaard O, Nielsen LH et al (2011) Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139. Br Med J 343:d6423\u2013d6423. \n                  https:\/\/doi.org\/10.1136\/bmj.d6423","journal-title":"Br Med J"},{"issue":"4","key":"774_CR84","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.maturitas.2012.01.007","volume":"71","author":"X Ruan","year":"2012","unstructured":"Ruan X, Seeger H, Mueck AO (2012) The pharmacology of nomegestrol acetate. Maturitas 71(4):345\u2013353. \n                  https:\/\/doi.org\/10.1016\/j.maturitas.2012.01.007","journal-title":"Maturitas"},{"issue":"1","key":"774_CR85","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.beem.2012.09.001","volume":"27","author":"KA Shaw","year":"2013","unstructured":"Shaw KA, Edelman AB (2013) Obesity and oral contraceptives: a clinician\u2019s guide. Best Pract Res Clin Endocrinol Metab 27(1):55\u201365. \n                  https:\/\/doi.org\/10.1016\/j.beem.2012.09.001","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40519-019-00774-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40519-019-00774-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40519-019-00774-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T22:22:15Z","timestamp":1600813335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40519-019-00774-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,12]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["774"],"URL":"https:\/\/doi.org\/10.1007\/s40519-019-00774-w","relation":{},"ISSN":["1590-1262"],"issn-type":[{"value":"1590-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,12]]},"assertion":[{"value":"20 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Author Prof. Linda Vignozzi has received research grant fundings from Theramex and from Bayer. The authors Dr. Sarah Cipriani, Dr. Tommaso Todisco, Dr. Irene Scavello, Dr. Vincenza Di Stasi, and Dr. Elisa Maseroli declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not deal directly with a study conducted on animals or humans by our research group.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}